Dent Neurologic

DENTNeuro_White

DENT Neurosciences Research Center

The Dent Neuroscience Research Center (DNRC) is a 501(c)(3) not-for-profit affiliate of DENT dedicated to outcomes research and education supported by foundations, industry and personal contributions. The DNRC is focused on developing comprehensive, clinically relevant, and cost effective solutions to complex neurological problems faced in our community.

Building awareness, fostering relationships, providing support and continuous education are at the forefront of the DENT philosophy. From providing our patients with the most up-to-date diagnostic and treatment options to assisting each in the best care and coping opportunities, we aim to fulfill the needs of the whole patient. Through foundation support and exceptional faculty leadership, DNRC is able to build upon the philosophy by providing advancement, support and education to our providers and partners.

Open Studies

Want to participate in a study?

Fill out the form below and one of our Research Coordinators will be in contact with you as soon as possible. If we currently do not have a study that is currently available for you, we will add you to our database for future studies.

  • All
  • Alzheimer's
  • Behavioral Health
  • Dizziness and Balance
  • Epilepsy
  • Headache/Migraine
  • Multiple Sclerosis
  • Parkisons Disease
  • Research Study
  • Stroke Center
  • Treatment-Resistant Depression
  • Uncategorized
All
  • All
  • Alzheimer's
  • Behavioral Health
  • Dizziness and Balance
  • Epilepsy
  • Headache/Migraine
  • Multiple Sclerosis
  • Parkisons Disease
  • Research Study
  • Stroke Center
  • Treatment-Resistant Depression
  • Uncategorized
Research Study

OXA1 Study

0XA1 Study This study will test if an investigational medicine ...
Read More →
Multiple Sclerosis

CogMS

CogMS – A Real-world Study Into Cognitive Impairment in People ...
Read More →
Research Study

Generation HD-2

Generation HD-2 This study will evaluate the safety, biomarkers, and ...
Read More →
Alzheimer's

ENVISION

ENVISION Trial  The objective of this study is to verify ...
Read More →
Parkisons Disease

PROSEEK

PROSEEK To Potentially Help Slow Progression for People with Early-stage ...
Read More →
Uncategorized

NRX- 101

Testing the hypothesis that treatment with NRX-101 is superior to standard of care (lurasidone) in improving symptoms of depression as measured by the total Montgomery ...
Read More →
Alzheimer's

ADNI4 Trial

ADNI4 Trial The ADNI4 is multi-center, a non-randomized, natural history, ...
Read More →
Multiple Sclerosis

Descartes-08

Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis
Read More →
Alzheimer's

ADNI3 Trial

ADNI3 Trial Dent is taking part in an observational study ...
Read More →
Dizziness and Balance

Hearing Aid Research

Hearing Aid Research Are you interested in participating in hearing ...
Read More →
Dizziness and Balance

Meniere’s Study

Meniere’s Study Have you been diagnosed with Meniere’s Disease? Do ...
Read More →
Epilepsy

STARS and STARS Extension

Studies to Assess the Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
Read More →
Alzheimer's

RETHINK-ALZ

Simufilam 100 mg for Mild to Moderate Alzheimer's Disease
Read More →
Treatment-Resistant Depression

RECOVER VNS

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in ...
Read More →
Uncategorized

X-TOLE: XEN1101 as Adjunctive Therapy in Focal-onset Epilepsy, with an Open-Label Extension

A clinical research study is underway for people with focal epilepsy currently taking 1-3 anti-epileptic drugs that are still experiencing frequent seizures. Three doses of ...
Read More →
Alzheimer's

PIONEER T3D: Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate Alzheimer’s Disease Subjects

PIONEER T3D: Clinical Study Evaluating Efficacy and Safety of T3D-959 ...
Read More →
Alzheimer's

Alzheimer’s Disease Neuroimaging Initiative 3 (ADNI3)

The Alzheimer’s Disease Neuroimaging Initiative (also known as ADNI) is a historic study of brain aging looking to help change the future for this disease.
Read More →
Uncategorized

Blog posts

Read More →
Behavioral Health

Break the stigma; mental health in sports is just as essential as physical health

Despite efforts to bring more awareness mental health, a stigma ...
Read More →
Headache/Migraine

CGBG Study

We are looking for adults ages 18 to 55 who have been diagnosed with migraine. The CGBC Study will consist of five visits over a ...
Read More →
Uncategorized

Vaccines and Pain/Fever Medicines

Dr. Gengo shares information from a recent article. The use of ...
Read More →

Subscribe To Our Newsletter

Sign up to receive email updates on announcements, new services added, company updates & more!

Research at Dent

The mission of research at DENT is to advance patient care by integrating the newest scientific advances into daily clinical practice. With support from organizations such as the Dent Family Foundation, the Blaszczykiewicz Foundation, and pharmaceutical clinical trials, DENT has established an impressive portfolio of publications and presentations in the scientific and clinical community.

Participating in research and clinical trials often provides an opportunity for patients to receive free medical care and medication. To learn if you might qualify, please visit Current Research Studies.

For research sponsors and investigators, we offer the opportunity to partner with an experienced team of researchers engaged in cutting-edge clinical practice and research in a wide variety of neurological disciplines.

Past & current research studies:

  • ALS (Lou Gehrig’s Disease)
  • Alzheimer’s Disease
  • Epilepsy
  • Memory Loss/Dementia
  • Migraine
  • Multiple Sclerosis
  • Neuroimaging
  • Neuro-oncology
  • Neuropathic Pain
  • Nuclear Medicine
  • Parkinson’s Disease
  • Psychiatry
  • Stroke
  • Vertigo

Giving Opportunities

The DNRC is funded through industry grants and clinical trial contracts, foundations, and community donations. Funds support need-based deserving initiatives related to the diagnosis and treatment of neurological disorders in patients from around the Western New York region.

Corporate or individual donors are welcome to designate their contribution to a specific specialty fund or have it applied to the general operating needs where it is most effective. Gifts can be made in many forms, including cash donations, proceeds from community benefits, corporate contributions and matching gifts, grants, planned gifts, gifts of honor or memorials, and more.

Please contact Maria Caserta, mcaserta@dentinstitute.com, to find out more about how you can help support our mission to bring the most comprehensive treatments to our neighbors and their families suffering with neurological disorders.

DNRC

Leadership

- Laszlo Mechtler, MD, Chief Medical Officer

- Fran M. Gengo, Pharm.D., Chief Science Officer

- Michelle Rainka, Pharm.D., CCRP, Secretary

- Joseph V. Fritz, Ph.D., Chief Administrative Executive

- Harry M. Dent III, Community Representative

- Maureen Tomczak-Griffin, Community Representative

- Anthony Baynes, Community Representative

The goal of DNRC is to advance neurologic care through pragmatic research and education at local, national and international levels.

Past Studies

Scroll to Top